Previous 10 | Next 10 |
Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by improved average selling prices, sustained demand, and the reduced impact of the COVID-19 pa...
Inogen, Inc. (INGN) Q4 2021 Earnings Conference Call February 24, 2022 05:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - Chief Executive Officer Mike Sergesketter - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Brett Fishbin - KeyB...
Inogen press release (NASDAQ:INGN): Q4 GAAP EPS of -$1.01 misses by $0.30. Revenue of $76.4M (+3.3% Y/Y) misses by $0.2M. For further details see: Inogen GAAP EPS of -$1.01 misses by $0.30, revenue of $76.4M misses by $0.2M
– Q4 2021 Total Revenue increased 3.3% year-over-year to $76.4 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the th...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022. The Company will host a c...
– Q4 2021 Total Preliminary Revenue of $75.9 to $76.9 million – – Provides Supply Chain and EU Operations Update – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use ...
- Ray Huggenberger Retires from Board - Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora was elected as Board Chairperson. Ms. Mora has served as...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s presentation at the 40 th Annual J.P. Morgan Healthcare Conference has been moved due to the confere...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40 th Annual J.P. Morgan Healthcare Conference. Inogen...
Inogen (NASDAQ:INGN) appoints Mike Sergesketter as interim CFO, succeeding Alison Bauerlein who will be staying with the Company in a transitional finance role through the 1Q22. The Company has retained a leading executive search firm to help with the search for a permanen...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...